This application seeks renewal of a highly successful CHRC which supports the transitional training of pediatric scientists studying molecular and cellular aspects of development in the Department of Pediatrics, University of Washington School of Medicine. The objectives of this program are to identify, encourage, and support promising young pediatricians by facilitating their acquisition of the skills and experience of the skills and experience required to initiate independent investigative careers. The new investigators and senior faculty advisors have laboratories at the University and its affiliated institutions, the Children's Hospital and Fred Hutchinson Cancer Research Center (FHCRC), where the Department of Pediatrics has established clinical and research programs. The Program Director oversees the day-to-day operations of the CHRC and its core laboratory. The core laboratory provides a focus for the CHRC new investigators and certain centralized services (e.g., transgenic mice). The core laboratory also take full advantage of the extensive shared resources and facilities services (e.g., transgenic mice). The core laboratory also takes full advantage of the extensive shared resources and facilities at each institution. There are two major sources of applicants to the program: fellowship programs within the Department of Pediatrics and active external recruitments. Particular emphasis is paid to nurturing the careers of female pediatric scientists, and substantive efforts are underway to recruit minority trainees to the Department and its CHRC. Support from this program will be the bridge that assures sufficient protected time for new pediatric investigators to acquire and consolidate the skills needed for them to successfully compete for individual research awards from NIH and similar entities.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Center Core Grants (P30)
Project #
2P30HD028834-06
Application #
2398151
Study Section
Special Emphasis Panel (ZHD1-DRG-H (03))
Project Start
1992-04-01
Project End
2002-11-30
Budget Start
1998-01-01
Budget End
1998-11-30
Support Year
6
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Washington
Department
Pediatrics
Type
Schools of Medicine
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Parisi, Melissa A; Lipman, Neil S; Clarke, Christine M et al. (2005) Evaluation of Hox11L1 in the fmc/fmc rat model of chronic intestinal pseudo-obstruction. J Pediatr Surg 40:1760-5
Cooper, Laurence J N; Topp, Max S; Pinzon, Cris et al. (2004) Enhanced transgene expression in quiescent and activated human CD8+ T cells. Hum Gene Ther 15:648-58
Leppig, Kathleen A; Sybert, Virginia P; Ross, Judith L et al. (2004) Phenotype and X inactivation in 45,X/46,X,r(X) cases. Am J Med Genet A 128A:276-84
Parisi, Melissa A; Baldessari, Audrey E; Iida, Malissa H K et al. (2003) Genetic background modifies intestinal pseudo-obstruction and the expression of a reporter gene in Hox11L1-/- mice. Gastroenterology 125:1428-40
Weldin, Josh; Jack, Rhona; Dugaw, Kathryn et al. (2003) Quercetin, an over-the-counter supplement, causes neuroblastoma-like elevation of plasma homovanillic acid. Pediatr Dev Pathol 6:547-51
Dinulos, James G H; Mentele, Laurel; Fredericks, L Page et al. (2003) Keratinocyte expression of human beta defensin 2 following bacterial infection: role in cutaneous host defense. Clin Diagn Lab Immunol 10:161-6
Johnston, Donna L; Meshinchi, Soheil; Opheim, Kent E et al. (2003) Progenitor cell involvement is predictive of response to induction chemotherapy in paediatric acute myeloid leukaemia. Br J Haematol 123:431-5
Parisi, Melissa A; Kapur, Raj P; Neilson, Ian et al. (2002) Hydrocephalus and intestinal aganglionosis: is L1CAM a modifier gene in Hirschsprung disease? Am J Med Genet 108:51-6
Bender, M A; Roach, J N; Halow, J et al. (2001) Targeted deletion of 5'HS1 and 5'HS4 of the beta-globin locus control region reveals additive activity of the DNaseI hypersensitive sites. Blood 98:2022-7
Leppig, K A; Disteche, C M (2001) Ring X and other structural X chromosome abnormalities: X inactivation and phenotype. Semin Reprod Med 19:147-57

Showing the most recent 10 out of 32 publications